IB
has provided technology assessments for potential
acquisitions, joint ventures, etc.:
Identification and vetting of potential gene sources to
create value-added transgenic commodity crops
Vetting facility purchases to set up cGMP facilities for
biologics
Review of clinical trail strategy for prognostic of
HIV/AIDS therapy success
